(MENAFN- ABN Newswire)

Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, announced that its majority owned subsidiary OxiDx Pty Ltd, in collaboration with The University of Western Australia, will today present groundbreaking performance data showing that Thoroughbred horses racing without oxidative stress (as measured by the OxiDx test) were 76% more likely to place and 49% more likely to win than horses with oxidative stress.
- New performance data in Thoroughbred racehorses shows racing without oxidative stress increased performance, with 88% of top-three finishers racing without oxidative stress: horses without oxidative stress were 76% more likely to place and 49% more likely to win
- OxiDx's patented technology detects a sensitive biomarker of systemic oxidative stress linked to muscle damage, poor recovery and increased injury risk
- The findings mark a key milestone confirming the OxiDx test's potential to enhance performance management and improve welfare outcomes in Thoroughbred racehorses
- Results presented today at the Australian Physiological Society (AuPS) Annual Scientific Meeting in Sydney, Australia
- Detecting musculoskeletal injuries is one of the largest problems facing the horse racing industry with a reported 85% of Thoroughbreds sustaining at least one injury during their twoand three-year-old racing seasons
- Partnering discussions ongoing for OxiDx targeting the Thoroughbred horse racing industry
Muscle injuries are a major issue in the racing industry, with it being difficult to objectively identify them, resulting in many going undetected. Approximately 85% of Thoroughbreds sustain at least one injury during their two- and three-year-old racing seasons, potentially as a result of undetected muscle injuries.
A study of 75 racehorses over 216 competitive events demonstrated that the absence of oxidative stress was strongly associated with superior racing performance. Using the proprietary OxiDx blood test, individual oxidative-stress baselines were established and monitored daily across the season. Horses racing without oxidative stress resulted in a higher likelihood of winning or placing in the top three (Probability (P) Proteomics International Laboratories (ASX:PIQ) is a wholly owned subsidiary and trading name of PILL, a medical technology company at the forefront of predictive diagnostics and bioanalytical services. The Company specialises in the area of proteomics - the industrial scale study of the structure and function of proteins. Proteomics International's mission is to improve the quality of lives by the creation and application of innovative tools that enable the improved treatment of disease.

Dr Richard Lipscombe Managing Director Proteomics International Laboratories Ltd T: +61 8 9389 1992 E:... Dirk van Dissel Investor Relations and Corporate Advisor Candour Advisory T: +61 408 326 367 E:... Matthew Wright Media and Public Relations NWR Communications T: +61 451 896 420 E:... Proteomics International (Europe) Plesmanweg 9, 7602 PD Almelo The Netherlands T: +31 85 40 11 173 E:...

MENAFN23112025000111011020ID1110386514